Related Experiment Video
Updated: Mar 15, 2026

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Early gut mucosal dysfunction in patients with acute pancreatitis
Haiyan Liu1, Weiqin Li, Xinying Wang
1Medical School of Nanjing University, Research Institute of General Surgery, Jinling Hospital, Nanjing, People's Republic of China.
Gut mucosal damage in acute pancreatitis (AP) is linked to disease severity and complications. Early intestinal barrier dysfunction may predict poor outcomes in AP patients.
Area of Science:
- Gastroenterology
- Critical Care Medicine
- Pathophysiology
Background:
- Acute pancreatitis (AP) is a serious condition with significant morbidity and mortality.
- Gut mucosal integrity plays a crucial role in the systemic response to AP.
- Understanding gut barrier dysfunction is key to managing AP complications.
Purpose of the Study:
- To investigate gut mucosal damage in acute pancreatitis (AP) patients.
- To correlate mucosal damage with endotoxemia, systemic inflammation, disease severity, septic complications, and patient outcomes.
Main Methods:
- A clinical study involving AP patients categorized by severity (mild, severe AP without organ dysfunction, severe AP with organ dysfunction) and healthy controls.
- Assessed intestinal permeability using lactulose/mannitol and d-xylose absorption ratios.
- Measured endotoxin and tumor necrosis factor alpha levels.
Main Results:
- Increased lactulose/mannitol absorption ratio and decreased d-xylose absorption in AP patients, more pronounced in severe cases.
- Significant positive correlation between mucosal permeability, endotoxin, and tumor necrosis factor alpha.
- Gut mucosal damage severity correlated with AP severity and septic complications.
Conclusions:
- Intestinal mucosal function is impaired early in AP, particularly in patients with organ dysfunction.
- This early gut barrier injury may drive multiple organ dysfunction and predict adverse outcomes in AP.
More Related Videos
07:10Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Acute Pancreatitis II: Clinical Manifestations and Management
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.